Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 24, 2023Journal of Medicinal Chemistry

Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death

View Full Paper
Ask AI
Bookmark
Share

Authors

ZWZhihang WangMTMixiao TanWSWen Su

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2023) studied this question.

synapsesocial.com/papers/6a027768c2bdcf1ab80237f8https://doi.org/10.1021/acs.jmedchem.3c00013
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging2012 · 53 citations
  2. 2Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER22001 · 11,633 citations
  3. 3Adaptive Randomization of Neratinib in Early Breast Cancer2016 · 468 citations